Trial Profile
Boost Vaccination Improves Humoral Immune Response Against Influenza Virus In Patients With Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2014
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections; Multiple myeloma
- Focus Therapeutic Use
- 20 Aug 2014 New trial record